Literature DB >> 3625036

Apoprotein E mediates the interaction of beta-VLDL with macrophages.

S R Bates, B A Coughlin, T Mazzone, J Borensztajn, G S Getz.   

Abstract

beta-Very low density lipoproteins (beta-VLDL) isolated from cholesterol-fed rhesus monkeys stimulated cholesteryl ester synthesis and accumulation in mouse peritoneal macrophages. The apoprotein specificity and requirement for the cell surface uptake of beta-VLDL was investigated by treating the beta-VLDL with trypsin (beta-VLDL (T], incubating the beta-VLDL (T) with other lipoproteins or apoproteins, reisolating the beta-VLDL (T) and measuring its biological activity which, for this study, is defined as the ability of the lipoprotein to stimulate cholesterol esterification in the macrophages. Trypsin treatment of beta-VLDL abolished its biological activity. Apoprotein analysis of the beta-VLDL (T) demonstrated the absence of intact apoproteins B-100, B-48, and E. The J774 macrophage-like cell line and mouse peritoneal macrophages responded similarly with respect to cholesterol esterification following incubation with inactive and treated beta-VLDL. The J774 macrophage-like cell line was used to establish the conditions necessary for the restoration of biologic activity to the trypsinized beta-VLDL. The loss of biological activity of beta-VLDL (T) could be reversed by restoring apoprotein E-containing LDL from hyperlipemic monkeys or purified apoprotein E. Apoprotein A-I had no such effect. The restored biological activity of the beta-VLDL (T) was proportional to the amount of apoprotein E acquired by the lipoprotein. beta-VLDL particles composed of apoprotein E and either intact or degraded apoprotein B-100 had comparable biological activity. Thus, intact apoprotein E, without intact apoprotein B, is a sufficient mediator for the biological activity and metabolism of beta-VLDL by macrophages and plays a major role in receptor-lipoprotein interaction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3625036

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  7 in total

1.  Increased clearance of plasma cholesterol after injection of apolipoprotein E into Watanabe heritable hyperlipidemic rabbits.

Authors:  N Yamada; H Shimano; H Mokuno; S Ishibashi; T Gotohda; M Kawakami; Y Watanabe; Y Akanuma; T Murase; F Takaku
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Macrophage uptake of low-density lipoprotein bound to aggregated C-reactive protein: possible mechanism of foam-cell formation in atherosclerotic lesions.

Authors:  Tao Fu; Jayme Borensztajn
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

3.  Apoprotein-independent binding of chylomicron remnants to rat liver membranes.

Authors:  J Borensztajn; T J Kotlar; S Y Chang
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

4.  Comparison of fatty acid and triacylglycerol metabolism of macrophages and smooth muscle cells.

Authors:  L M Bergstraesser; S R Bates
Journal:  Lipids       Date:  1988-07       Impact factor: 1.880

5.  Apolipoprotein E prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.

Authors:  N Yamada; I Inoue; M Kawamura; K Harada; Y Watanabe; H Shimano; T Gotoda; M Shimada; K Kohzaki; T Tsukada
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

6.  The influence of particle size and multiple apoprotein E-receptor interactions on the endocytic targeting of beta-VLDL in mouse peritoneal macrophages.

Authors:  I Tabas; J N Myers; T L Innerarity; X X Xu; K Arnold; J Boyles; F R Maxfield
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

7.  Interaction between VLDL and phosphatidylcholine liposomes generates new γ-LpE-like particles.

Authors:  Agnieszka Ćwiklińska; Barbara Kortas-Stempak; Anna Gliwińska; Anastasis Pacanis; Agnieszka Kuchta; Małgorzata Wróblewska
Journal:  Lipids       Date:  2014-02       Impact factor: 1.880

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.